Consequently, treatment of murine models of DMD with tyrosine kinase inhibitors that block the PDGFRα such as imatinib, crenolanib and nintedanib, decreased fibrosis and improved muscle function of these animals (40, 42, 44). The gene discussed is PDGFRA; the disease is Duchenne muscular dystrophy.